170 related articles for article (PubMed ID: 15265190)
21. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
22. [Bone mineral density in children with long-term antiepileptic therapy].
Dimić M; Dimić A; Milosević Z; Vojinović J
Srp Arh Celok Lek; 2013; 141(5-6):329-32. PubMed ID: 23858802
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density in ambulatory children with epilepsy.
Yaghini O; Tonekaboni SH; Amir Shahkarami SM; Ahmad Abadi F; Shariat F; Abdollah Gorji F
Indian J Pediatr; 2015 Mar; 82(3):225-9. PubMed ID: 25106841
[TBL] [Abstract][Full Text] [Related]
24. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
25. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy.
Sato Y; Kondo I; Ishida S; Motooka H; Takayama K; Tomita Y; Maeda H; Satoh K
Neurology; 2001 Aug; 57(3):445-9. PubMed ID: 11502911
[TBL] [Abstract][Full Text] [Related]
26. Antiepileptic drug-induced osteopenia in ambulatory epileptic children receiving a standard vitamin D3 supplement.
Tekgul H; Dizdarer G; Demir N; Ozturk C; Tutuncuoglu S
J Pediatr Endocrinol Metab; 2005 Jun; 18(6):585-8. PubMed ID: 16042326
[TBL] [Abstract][Full Text] [Related]
27. [Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy].
Zhang J; Wang KX; Wei Y; Xu MH; Su JM; Bao YG; Zhao SY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):96-8. PubMed ID: 20199720
[TBL] [Abstract][Full Text] [Related]
28. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy.
Verrotti A; Agostinelli S; Coppola G; Parisi P; Chiarelli F
Eur J Neurol; 2010 Feb; 17(2):232-7. PubMed ID: 19682062
[TBL] [Abstract][Full Text] [Related]
29. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Lin CM; Fan HC; Chao TY; Chu DM; Lai CC; Wang CC; Chen SJ
BMC Pediatr; 2016 May; 16():61. PubMed ID: 27142370
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.
Rahimdel A; Dehghan A; Moghadam MA; Ardekani AM
Electron Physician; 2016 Nov; 8(11):3257-3265. PubMed ID: 28070260
[TBL] [Abstract][Full Text] [Related]
31. Bone remodeling and bone mineral density during pregnancy.
Ulrich U; Miller PB; Eyre DR; Chesnut CH; Schlebusch H; Soules MR
Arch Gynecol Obstet; 2003 Oct; 268(4):309-16. PubMed ID: 14504876
[TBL] [Abstract][Full Text] [Related]
32. The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid.
Villegas-Martínez I; de-Miguel-Elízaga I; Carrasco-Torres R; Marras C; Canteras-Jordana M; Yedra-Guzmán MJ; Martínez-Villanueva M; Tortosa-Conesa D; Martín-Fernández J
Pharmacogenet Genomics; 2016 Mar; 26(3):126-32. PubMed ID: 26727275
[TBL] [Abstract][Full Text] [Related]
33. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.
Phabphal K; Limapichat K; Sathirapanya P; Setthawatcharawanich S; Leelawattana R; Thammakumpee N; Thamaprasit A; Geater A
Epileptic Disord; 2008 Sep; 10(3):213-8. PubMed ID: 18782690
[TBL] [Abstract][Full Text] [Related]
34. Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies.
Min L; Chunyan W; Biaoxue R
BMC Pediatr; 2020 Mar; 20(1):97. PubMed ID: 32122313
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of bone turnover in epileptic children using oxcarbazepine.
Cansu A; Yesilkaya E; Serdaroğlu A; Hirfanoğlu TL; Camurdan O; Gülbahar O; Gücüyener K; Cinaz P
Pediatr Neurol; 2008 Oct; 39(4):266-71. PubMed ID: 18805365
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of bone atrophy by microdensitometry and effect of active vitamin D3 (1 alpha-OH-D3) administration in patients receiving anticonvulsants].
Takeno Y
No To Shinkei; 1989 Sep; 41(9):887-93. PubMed ID: 2511908
[TBL] [Abstract][Full Text] [Related]
37. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of bone mineral density using digital image processing in children receiving anticonvulsants].
Suzuki K; Ueda S; Umezu R; Matsuoka H; Sugihara S
No To Hattatsu; 2007 Sep; 39(5):351-5. PubMed ID: 17879608
[TBL] [Abstract][Full Text] [Related]
39. Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne.
Tekin NS; Ozdolap S; Sarikaya S; Keskin SI
Int J Dermatol; 2008 Jun; 47(6):622-5. PubMed ID: 18477161
[TBL] [Abstract][Full Text] [Related]
40. Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients.
El-Haggar SM; Mostafa TM; Allah HMS; Akef GH
Arq Neuropsiquiatr; 2018 Jul; 76(7):452-458. PubMed ID: 30066796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
